Related references
Note: Only part of the references are listed.A unified anti-mutant dosing strategy
Xilin Zhao et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae
Daniel E. Rozen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
The biological cost of mutational antibiotic resistance: any practical conclusions?
Dan I. Andersson
CURRENT OPINION IN MICROBIOLOGY (2006)
European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe
Matus Ferech et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
The competitive cost of antibiotic resistance in Mycobacterium tuberculosis
Sebastien Gagneux et al.
SCIENCE (2006)
Darwinian evolution can follow only very few mutational paths to fitter proteins
DM Weinreich et al.
SCIENCE (2006)
Role of novel gyrA mutations in the suppression of the fluoroquinolone resistance genotype of vaccine strain Salmonella Typhimurium vacT (gyrA D87G)
A Preisler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Molecular genetic and structural modeling studies of Staphylococcus aureus RNA polymerase and the fitness of rifampin resistance genotypes in relation to clinical prevalence
AJ O'Neill et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The quinolones: Past, present, and future
VT Andriole
CLINICAL INFECTIOUS DISEASES (2005)
Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections
PK Lindgren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: Impact of priop fluoroquinolone use?
CV Gould et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2004)
Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections
PK Lindgren et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria
G Kahlmeter et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Regulation of bacterial drug export systems
S Grkovic et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2002)
Mechanisms of action of antimicrobials: Focus on fluoroquinolones
DC Hooper
CLINICAL INFECTIOUS DISEASES (2001)
Topoisomerase IV, alone, unknots DNA in E-coli
RW Deibler et al.
GENES & DEVELOPMENT (2001)
An efficient recombination system for chromosome engineering in Escherichia coli
DG Yu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies
H Hvidberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
